Ignite Creation Date:
2024-05-06 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04714593
Status:
UNKNOWN
Last Update Posted:
2021-01-22
First Post:
2021-01-07
Brief Title:
Targeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Acute B Lymphocytic Leukemia
Sponsor:
Shanxi Province Cancer Hospital
Organization:
Shanxi Province Cancer Hospital
Organization Data
Organization:
Shanxi Province Cancer Hospital
Class:
OTHER
Study ID:
CAR-T SXZL02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanxi Province Cancer Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Shanghai Ultra-T Immune Therapeutics Co LTD | UNKNOWN |